Home Grail Inc.

Grail Inc.

Significant Progress with Multi Cancer Early Detection Test

GRAIL, Inc., announced that its multi cancer early detection test has been granted Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The investigational blood test is in development for the early detection of multiple cancer types in individuals aged 50 or older.